Medtronic, Inc. (MDT) Tops Q4 EPS by 1c; Guides FY13 Sales
Tweet
Share
E-mailGet Alerts MDT Hot Sheet
Price: $92.77 +0.18%
EPS Growth %: -2.2%
Financial Fact:
Selling, general, and administrative expense: 1.49B
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: -2.2%
Financial Fact:
Selling, general, and administrative expense: 1.49B
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Medtronic, Inc. (NYSE: MDT) reported Q4 EPS of $0.99, $0.01 better than the analyst estimate of $0.98. Revenue for the quarter came in at $4.3 billion versus the consensus estimate of $4.23 billion.
Medtronic, Inc. sees FY2013 EPS of $3.62-$3.70, versus the consensus of $3.66. Sees sales up 2-4 percent.
For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.
Medtronic, Inc. sees FY2013 EPS of $3.62-$3.70, versus the consensus of $3.66. Sees sales up 2-4 percent.
For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Nucor projects Q3 2026 earnings above prior year, below estimates
- Piper Sandler Reiterates Overweight Rating on Block Inc. (XYZ)
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
